Global Biotechnology

MarketLine
33 Pages - MLINE10423
$350.00

Summary
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons To Buy
- What was the size of the Global biotechnology market by value in 2016?

- What will be the size of the Global biotechnology market in 2021?

- What factors are affecting the strength of competition in the Global biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the global's biotechnology market?

Key Highlights
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The global biotechnology market is expected to generate total revenues of $358.9bn in 2016, representing a compound annual growth rate (CAGR) of 8.8% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $207.0bn, equivalent to 57.7% of the market's overall value.

The global costs of vaccines have been driven upwards by years of speculation in the biotechnology industry. Globally biotechnology is attracting a lot of investment, as can be seen in the strong growth witnessed by many countries.

'

Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Amgen, Inc.
Covance Inc.
Merck and Co., Inc.
F. Hoffmann-La Roche Ltd
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

Table 1: Global biotechnology industry value: $ billion, 2012-16(e)
Table 2: Global biotechnology industry category segmentation: $ billion, 2016(e)
Table 3: Global biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: Global biotechnology industry value forecast: $ billion, 2016-21
Table 5: Amgen, Inc.: key facts
Table 6: Amgen, Inc.: key financials ($)
Table 7: Amgen, Inc.: key financial ratios
Table 8: Covance Inc.: key facts
Table 9: Merck and Co., Inc.: key facts
Table 10: Merck and Co., Inc.: key financials ($)
Table 11: Merck and Co., Inc.: key financial ratios
Table 12: F. Hoffmann-La Roche Ltd: key facts
Table 13: F. Hoffmann-La Roche Ltd: key financials ($)
Table 14: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 15: F. Hoffmann-La Roche Ltd: key financial ratios

Figure 1: Global biotechnology industry value: $ billion, 2012-16(e)
Figure 2: Global biotechnology industry category segmentation: % share, by value, 2016(e)
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2016(e)
Figure 4: Global biotechnology industry value forecast: $ billion, 2016-21
Figure 5: Forces driving competition in the global biotechnology industry, 2016
Figure 6: Drivers of buyer power in the global biotechnology industry, 2016
Figure 7: Drivers of supplier power in the global biotechnology industry, 2016
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2016
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2016
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2016
Figure 11: Amgen, Inc.: revenues and profitability
Figure 12: Amgen, Inc.: assets and liabilities
Figure 13: Merck and Co., Inc.: revenues and profitability
Figure 14: Merck and Co., Inc.: assets and liabilities
Figure 15: F. Hoffmann-La Roche Ltd: revenues and profitability
Figure 16: F. Hoffmann-La Roche Ltd: assets and liabilities

Amgen, Inc.
Covance Inc.
Merck and Co., Inc.
F. Hoffmann-La Roche Ltd

$350.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838